Seoul [South Korea] July 13 (ANI/Global Economic): Genexine announced on the 12th that it has signed a joint research agreement with PHI Biomed and POSTECH (Pohang University of Science and Technology) to develop a next-generation COVID-19 mRNA vaccine.